Eris Lifesciences Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review

The Eris Lifesciences stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Eris Lifesciences share price prediction as one data point and not as a guarantee of future performance.

This article reviews every dimension of the Eris Lifesciences stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.

Click Here – Get Free Investment Predictions

What Analysts Predict for Eris Lifesciences Stock in 2026

Analyst consensus on the Eris Lifesciences stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and ICICI Securities. All figures are sourced from publicly available research and should be verified before publishing.

Brokerage	Rating	Eris Lifesciences Stock Prediction (Rs)	Updated
JM Financial	Buy	Rs 1600	2026
ICICI Securities	Buy	Rs 1550	2026
Analyst Consensus	—	Rs 1575	2026

The Eris Lifesciences stock prediction range reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Eris Lifesciences stock forecast from the current price of Rs 1,383.7 may or may not be realised by end of 2026.

Eris Lifesciences Company Overview

Eris Lifesciences is a significant player in India’s pharmaceutical industry with a presence across domestic formulations, US generics and specialty segments. The Eris Lifesciences stock prediction for 2026 reflects both the pipeline growth potential and regulatory risk.

Metric	Value
NSE Ticker	ERIS
Sector	Pharmaceuticals and Healthcare
CMP	Rs 1,383.7 (2026)
52 Week High	Rs 1,910
52 Week Low	Rs 1,200
Market Cap	Rs 19,137 Cr
P/E Ratio	75.4
Eris Lifesciences Stock Prediction Consensus (12M)	Rs 1575

Eris Lifesciences Stock Prediction by Time Horizon

Analysts split the Eris Lifesciences share price prediction across time frames as near-term drivers differ materially from the long-term view.

Short-Term Eris Lifesciences Stock Prediction

The near-term Eris Lifesciences stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 1,383.7 are being watched closely. A short-term Eris Lifesciences share price prediction carries the most uncertainty of any time horizon.

12-Month Eris Lifesciences Stock Prediction

JM Financial targets Rs 1600 (Buy) and ICICI Securities targets Rs 1550 (Buy). Most desks refresh their Eris Lifesciences stock forecast within two to four weeks of each quarterly earnings print. The Eris Lifesciences share price prediction should be verified against the most recent analyst reports.

Long-Term Eris Lifesciences Stock Prediction

The long-term Eris Lifesciences stock prediction is built on assumptions about demand recovery, margin expansion and revenue diversification in the Pharmaceuticals and Healthcare sector. The long-term Eris Lifesciences share price prediction carries the most uncertainty and should be treated as directional guidance only.

Eris Lifesciences Stock Forecast: Key Factors

The following four factors appear consistently in research reports on the Eris Lifesciences stock prediction and are the primary inputs into the bull and bear case scenarios.

US Generic Revenue

US generics revenue is the most watched metric in the Eris Lifesciences stock forecast. USFDA approval timelines and price erosion rates directly affect the Eris Lifesciences share price prediction from most research desks.

Domestic Formulations Growth

Domestic formulation growth provides a stable base that supports the Eris Lifesciences stock prediction even when export growth faces headwinds.

R&D Pipeline

The depth and commercialization pace of the R&D pipeline is a key variable in the long-term Eris Lifesciences share price prediction. New product approvals are cited as catalysts for the Eris Lifesciences stock prediction.

EBITDA Margin

Sustained EBITDA margin expansion is typically the basis for the bullish Eris Lifesciences stock forecast. Margin recovery strengthens the Eris Lifesciences share price prediction from most research desks.

Eris Lifesciences Stock Prediction: Bull and Bear Scenarios

Scenario	Eris Lifesciences Stock Prediction	Key Conditions
Bull Case	Rs 1600	Strong execution, margin improvement, favourable macro and sector re-rating
Base Case	Rs 1575	Steady performance, gradual recovery, margins hold, growth on track
Bear Case	Rs 1200	Demand deterioration, margin pressure, sector de-rating and macro headwinds

The bull case Eris Lifesciences stock forecast of Rs 1600 assumes most positive variables converge. The base case of Rs 1575 is the analyst consensus and may or may not be achieved.

How Analysts Are Reading the Eris Lifesciences Stock Story

Analyst reviews of the Eris Lifesciences share price prediction highlight the company’s core strengths in Pharmaceuticals and Healthcare alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the Eris Lifesciences stock prediction consensus is built on real business strengths set against real risks.

Key Risks to the Eris Lifesciences Stock Prediction

USFDA Regulatory Risk

Import alerts and warning letters from the USFDA are the most significant risks to the Eris Lifesciences stock prediction. A facility closure would force an immediate sharp revision to the Eris Lifesciences share price prediction.

Price Erosion in the US

Pricing pressure in US generics compresses the revenue per product and affects the Eris Lifesciences stock forecast. Aggressive price erosion pushes the Eris Lifesciences share price prediction toward the bear case.

R&D Execution Risk

Delays in clinical trials or approval failures affect the Eris Lifesciences stock prediction. The Eris Lifesciences share price prediction is particularly sensitive to key pipeline asset announcements.

Currency Risk

A strengthening rupee against the dollar reduces export realisation and affects the Eris Lifesciences stock forecast. Currency risk is embedded in conservative Eris Lifesciences share price prediction models.

How to Monitor the Eris Lifesciences Stock Forecast

Track the Eris Lifesciences share price prediction consensus quarterly. After every earnings release, most brokerages revise their Eris Lifesciences stock forecast within two weeks. Comparing the revised Eris Lifesciences stock prediction to the previous estimate tells you whether analyst sentiment is improving or deteriorating.

Compare the current price of Rs 1,383.7 with the analyst target range of Rs 1600 to Rs 1550. A wide Eris Lifesciences stock prediction band reflects genuine uncertainty, so position size should reflect that range rather than the midpoint alone.

Review the Eris Lifesciences share price prediction every quarter against key business metrics for the Pharmaceuticals and Healthcare sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.

Check Live Eris Lifesciences Fundamentals on the Univest Screener

Conclusion

The Eris Lifesciences stock prediction for 2026 reflects the analyst community’s assessment of Eris Lifesciences’s competitive position, earnings trajectory and macro environment. JM Financial holds a Buy stance with a target of Rs 1600 while ICICI Securities has a Buy rating with a target of Rs 1550, giving an analyst consensus of Rs 1575.

The Eris Lifesciences stock forecast is set against near-term risks that make the Eris Lifesciences share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking changes in the Eris Lifesciences stock prediction over time is more valuable than relying on any single estimate.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Download the Univest iOS App or Univest Android App to track the live Eris Lifesciences stock prediction and share price prediction changes in real time.

Frequently Asked Questions on Eris Lifesciences Stock Prediction 2026

What is the Eris Lifesciences stock prediction for 2026?

Ans. The Eris Lifesciences stock prediction for 2026 is based on analyst consensus from JM Financial and ICICI Securities. The consensus target is Rs 1575. All estimates may or may not be achieved.

Is the Eris Lifesciences stock prediction bullish or bearish?

Ans. JM Financial has a Buy rating with target Rs 1600. ICICI Securities has a Buy rating with target Rs 1550. The Eris Lifesciences stock forecast reflects genuine analyst diversity of opinion.

What is the Eris Lifesciences share price prediction based on fundamentals?

Ans. The Eris Lifesciences share price prediction rests on the US generic pipeline, domestic growth, EBITDA margin and regulatory compliance track record. Analysts tracking Eris Lifesciences closely cite these as the primary drivers of the 2026 outlook.

What is the long-term Eris Lifesciences stock prediction?

Ans. The long-term Eris Lifesciences stock prediction assumes the company sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 1575 is the nearest reliable anchor point.

What are the key risks to the Eris Lifesciences stock prediction?

Ans. The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every Eris Lifesciences stock prediction should be read alongside its risk assumptions.

What does the Eris Lifesciences stock forecast say for 2026?

Ans. JM Financial: Buy target Rs 1600. ICICI Securities: Buy target Rs 1550. These Eris Lifesciences share price prediction estimates may or may not prove accurate.

Where can I track the latest Eris Lifesciences stock prediction?

Ans. Track the latest Eris Lifesciences stock prediction on the NSE and BSE websites and on the Univest app and screener for live price and updated analyst targets.